| 1 |
Sinclair DA, Guarente L. Extrachromosomal rDNA circles- a cause of aging in Yeast[J]. Cell,1997,91(7):1033-1042.
|
| 2 |
Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to calorie restriction[J]. Proc Natl Acad Sci USA,2004,101(45):15998-16003.
|
| 3 |
Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in caenorhabditis elegans[J]. Nature, 2001, 410(8625):227-230.
|
| 4 |
Howitz KT, Bitterman KJ, Sinclair DA. Small molecule activators of sirtuins extend saccharomyces cerevisiae lifespan[J]. Nature,2003,425(6954):191-196.
|
| 5 |
Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function[J]. Biochem J,2007,404(1):1-13.
|
| 6 |
Fau HK, Fau WS, Fau YK. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function[J]. J Biol Chem,2010,285(17):13045-13056.
|
| 7 |
He W, Wang Y, Hao CM. Sirt1 activation protects the mouse renal medulla from oxidative injury[J]. J Clin Invest, 2010, 120(4):1056-1068.
|
| 8 |
Kume S, Haneda M, Koya D. Silent information regulator 2 (Sirt1)attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation [ J]. Free Radic Biol Med, 2006, 40 (12):2175-2182.
|
| 9 |
Zhang D, Li S, Kone BC. Sirtuin 1 functionally and physically interacts with disruptor of telomeric silencing-1 to regulate alpha-ENaC transcription in collecting duct [J]. J Biol Chem,2009,284(31):20917-20926.
|
| 10 |
Ss W, Kd L. Diagnosis, epidemiology and outcomes of acute kidney injury[J]. Clin J Am Soc Nephrol,2008,3(3):844-861.
|
| 11 |
Lempiainen J, Finckenberg P, Mervaala EM. Caloric restriction ameliorates kidney ischaemia/reperfusion injury through PGC-1 alpha-eNOS pathway and enhanced autophagy[J]. Acta Physiol(Oxf),2013,208(4):410-421.
|
| 12 |
DH K, YJ J, JE L. Sirt1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53 [J]. Am J Physiol Renal Physiol,2011,301(2): F427-F435.
|
| 13 |
Kalakeche R, Hato T, Dagher PC. Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment[J]. J Am Soc Nephrol,2011,22(8):1505-1516.
|
| 14 |
Fan H, Yang HC, Hao CM. The histone deacetylase, Sirt1,contributes to the resistance of young mice to ischemia/reperfusioninduced acute kidney injury[J]. Kidney Int, 2013, 83 (3):404-413.
|
| 15 |
Funk JA, Schnellmann RG. Accelerated recovery of renal mitochondrial and tubule homeostasis with Sirt1/PGC-1alpha activation following ischemia-reperfusion injury[J]. Toxicol Appl Pharmacol,2013,273(2):345-354.
|
| 16 |
Simic P, Williams EO, Guarente L. Sirt1 suppresses the epithelialto-mesenchymal transition in cancer metastasis and organ fibrosis[J]. Cell Rep,2013,3(4):1175-1186.
|
| 17 |
Edelstein CL. Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease[J]. Clin J Am Soc Nephrol, 2008, 3(4):1219-1226.
|
| 18 |
Wong S, Weber JD. Deacetylation of the retinoblastoma tumour suppressor protein by Sirt1 [J]. Biochem J, 2007, 407 (3):451-460.
|
| 19 |
Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms[J]. Genes Dev,2000,14(19):2393-2409.
|
| 20 |
Zhou X, Fan LX, Li X. Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease[J]. J Clin Invest,2013,123(7):3084-3098.
|
| 21 |
Hasegawa K, Wakino S, Yoshioka K, et al. Kidney-specific overexpression of Sirt1 protects against acute kidney injury by retaining peroxisome function [J]. J Biol Chem, 2010, 285(17):13045-13056.
|
| 22 |
Maeda S, Koya D, Araki S, et al. Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes[J].Clin Exp Nephrol,2011,15(3):381-390.
|
| 23 |
Kitada M, Kume S, Imaizumi N, et al. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway[J]. Diabetes,2011,60(2):634-643.
|
| 24 |
Kim MY, Lim JH, Youn HH, et al. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-Sirt1-PGC1alpha axis in db/db mice[J].Diabetologia,2013,56(1):204-217.
|
| 25 |
Mattagajasingh I, Kim CS, Naqvi A, et al. Sirt1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase[J]. Proc Natl Acad Sci USA, 2007, 104(37):14855-14860.
|
| 26 |
Miyazaki R, Ichiki T, Hashimoto T, et al. Sirt1, a longevity gene,downregulates angiotensin Ⅱtype 1 receptor expression in vascular smooth muscle cells[J]. Arterioscler Thromb Vasc Biol, 2008, 28(7):1263-1269.
|
| 27 |
Li J, Qu X, Ricardo SD, et al. Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3[J].Am J Pathol,2010,177(3):1065-1071.
|
| 28 |
Huang XZ, Wen D, Zhang M, et al. Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway[J]. J Cell Biochem,2014,115(5):996-1005.
|
| 29 |
Kume S, Uzu T, Horiike K, et al. Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney [J]. The Journal of clinical investigation,2010,120(4):1043-1055.
|
| 30 |
Poulsen MM, Vestergaard PF, Clasen BF, et al. High-dose resveratrol supplementation in obese men: an investigator-initiated,randomized, placebo-controlled clinical trial of substrate metabolism,insulin sensitivity, and body composition[J]. Diabetes, 2013, 62(4):1186-1195.
|